Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
García de Masdevall
M D
MD
Immunology Lab, Hospital de Cruces, Baracaldo, Vizcaya, Spain.
Arrieta
A
A
Riñón
M
M
Altés
C
C
Arranz
C
C
D000961:Antilymphocyte Serum / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology*; D001803:Blood Transfusion; D004229:Dithiothreitol / Q000008:administration & dosage*; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis*; D007518:Isoantibodies / Q000032:analysis; D016030:Kidney Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000276:immunology* / Q000517:prevention & control; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum; D001323:Autoantibodies; D007075:Immunoglobulin M; D007518:Isoantibodies; D004229:Dithiothreitol